Intensive care admissions and associated severity of influenza b versus a during influenza B vaccine-mismatched seasons

Maya Korem, Efrat Orenbuch-Harroch, Eli Ben-Chetrit, Sarah Israel, Matan J. Cohen, Sigal Sviri, Phillip D. Levin, Michal Mandelboim, Dana G. Wolf*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Patients admitted to hospital with influenza B and A in Jerusalem, Israel, during the 2015-2016 and 2017-2018 influenza seasons demonstrated similar rates of intensive care unit (ICU) admission and associated disease severity. Most (63%) influenza B ICU patients received influenza B-mismatched trivalent vaccine. These findings call into question the equivalence of trivalent and quadrivalent vaccines in preventing severe influenza B.

Original languageEnglish
Pages (from-to)1049-1052
Number of pages4
JournalClinical Infectious Diseases
Volume69
Issue number6
DOIs
StatePublished - 30 Aug 2019
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.

Keywords

  • influenza B
  • influenza vaccine
  • intensive care admission
  • quadrivalent influenza vaccine
  • trivalent influenza vaccine

Fingerprint

Dive into the research topics of 'Intensive care admissions and associated severity of influenza b versus a during influenza B vaccine-mismatched seasons'. Together they form a unique fingerprint.

Cite this